Emerging nanocarrier platforms aim to improve drug bioavailability and target specificity ( Naqvi et al., 2020
This leads to increased fullness, reduced appetite, and significant weight loss
Obese patients with type 2 diabetes submitted to banded gastric bypass: greater incidence of dumping syndrome
Liraglutide led to modest weight loss and improved physical function but did not significantly reduce knee pain or increase daily physical activity
The increased blood flow also amplifies the effectiveness of all other active ingredients
Few clinical trials assessing the efficacy of NAC as adjunctive treatment in patients with BD have shown promising results (189, 281, 289, 294298), with benefits in depressive symptoms of BD patients (63, 189, 285, 289), but not as maintenance treatment (189, 294)